Efficacy and factors associated with reactivation following intravitreal ranibizumab or conbercept for retinopathy of prematurity. [PDF]
Liu Q +8 more
europepmc +1 more source
Mannose-modified miR-223 nanoparticles remodel pathological microenvironment to suppress inflammation and angiogenesis for neovascular AMD therapy. [PDF]
Wang Y +8 more
europepmc +1 more source
Comparison of the efficacy and safety of conbercept plus panretinal photocoagulation versus panretinal photocoagulation alone for proliferative diabetic retinopathy: A multicenter, prospective, randomized controlled study. [PDF]
Tang W +9 more
europepmc +1 more source
Association between systemic blood pressure control and outcomes of Conbercept treatment for macular edema secondary to retinal vein occlusion. [PDF]
Wu Q +6 more
europepmc +1 more source
Posterior reversible encephalopathy syndrome across 22 VEGF-pathway inhibitors in the FDA adverse event reporting system: reporting patterns and reporting-interval characteristics. [PDF]
Li J, Cheng Y, Yang Y.
europepmc +1 more source
Adjuvant mecobalamin for anti-VEGF therapy in retinal vein occlusion: protocol of a single-centre, randomised, double-blinded controlled trial. [PDF]
Liu KY +8 more
europepmc +1 more source
Adjuvant Anti-VEGF in Vitrectomy for Proliferative Diabetic Retinopathy: Current Evidence, Timing Considerations, and Clinical Implications. [PDF]
Coelho-Costa I, Falcão M, Goldhardt R.
europepmc +1 more source
Preoperative intravitreal injection of conbercept improves the efficacy of neovascular glaucoma surgery. [PDF]
Chen L, Zhou J, Lou Q, Chen T, Cheng Y.
europepmc +1 more source
Evaluation of Ahmed glaucoma valve versus Ex-PRESS shunt implantation with conbercept therapy in neovascular glaucoma. [PDF]
Zhou L, Liu Y.
europepmc +1 more source
Effects of anti-VEGF therapy on choroidal thickness in eyes with diabetic macular edema. [PDF]
Shi XN +4 more
europepmc +1 more source

